Boehringer Ingelheim Launches Rehabilitation Center in Chengdu at CIIE

The 5th China International Import Expo (CIIE) saw the unveiling of Boehringer Ingelheim’s Consanas (Chengdu) Rehabilitation Center, a joint effort between the German major and the Chengdu Wenjiang local government. This marks a significant step in enhancing stroke rehabilitation medicine in China.

Center Profile
The Consanas (Chengdu) Rehabilitation Center, focused on neurorehabilitation, will combine Boehringer Ingelheim’s whole course solutions for stroke to provide patients with individualized, standardized, and professionalized health management services. The center aims to improve outcomes for stroke patients through comprehensive and tailored rehabilitation programs.

Partnership Background
Previously, Boehringer Ingelheim and the Chengdu Wenjiang local government agreed to set up a brick-and-mortar Consanas (Chengdu) rehabilitation center and Internet hospital. This collaboration is designed to leverage Boehringer Ingelheim’s expertise in stroke management and the local government’s resources to create a state-of-the-art rehabilitation facility.

Future Prospects
The opening of the Consanas (Chengdu) Rehabilitation Center underscores Boehringer Ingelheim’s commitment to improving healthcare outcomes in China. By focusing on neurorehabilitation, the center aims to provide high-quality care and support for stroke patients, contributing to the broader goal of enhancing healthcare services in the region.-Fineline Info & Tech

Insight, China's Pharmaceutical Industry